CT Pulmonary Angiography is the gold standard to rule out Pulmonary Embolism. When a study does not result in a diagnostic quality exam without limitation, physicians must choose to reimage; to conduct other tests with reduced quality results; or to proceed with treatment.

According to a recent Albany Medical Center abstract*, 30% of the PE studies conducted in the Emergency Department showed suboptimal results. Patients with suboptimal interpretations were subjected to additional imaging studies and/or received medical therapy. In some cases, patients were admitted to the hospital for further PE diagnosis consideration. As a result, the suboptimal interpretations substantially impacted healthcare resource utilization and increased healthcare costs.

Research has shown that MEDRAD's P3T™ Cardiac software has resulted in a higher percentage of PE exams ranked as diagnostic without limitation.

P3T Cardiac has also been shown to result in better contrast enhancement of the pulmonary arteries when compared to standard exams, albeit a slightly higher contrast dose than standard protocol.

MEDRAD’s P3T software is radiology’s only contrast injection application that enables clinicians to automatically calculate and deliver personalized contrast injection protocols according to patient, procedure, and prescribed physician parameters. P3T applications increase consistency of contrast injection delivery among clinicians and across a wide variety of patient types.

*Weinstein JM; Burton JH; Katz BS, Department of Emergency Medicine; Albany Medical Center; Albany, NY